Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders

Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma

NCT00720174 ·Status: COMPLETED ·Phase: PHASE1

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma

NCT00108121 ·Status: COMPLETED ·Phase: PHASE2

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery

NCT00004075 ·Status: COMPLETED ·Phase: PHASE1

A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies

NCT02498665 ·Status: COMPLETED ·Phase: PHASE1

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Malignant Melanoma

NCT00104897 ·Status: COMPLETED ·Phase: PHASE2

Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery

NCT00848016 ·Status: COMPLETED ·Phase: PHASE2

Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma

NCT00112463 ·Status: COMPLETED ·Phase: PHASE2

Thalidomide in Treating Patients With Gynecologic Sarcomas

NCT00006005 ·Status: COMPLETED ·Phase: PHASE2

Compassionate Use of Aldoxorubicin in Sarcoma Patients Chemotherapy

NCT02570412 ·Status: NO_LONGER_AVAILABLE

Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers

NCT00003207 ·Status: COMPLETED ·Phase: PHASE1

Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma

NCT00019123 ·Status: COMPLETED ·Phase: PHASE2

Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma

NCT04941274 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma

NCT00002985 ·Status: COMPLETED ·Phase: PHASE3

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

NCT00004065 ·Status: COMPLETED ·Phase: PHASE1

Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS

NCT00001059 ·Status: COMPLETED ·Phase: PHASE2

Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy

NCT00003856 ·Status: UNKNOWN ·Phase: PHASE2

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

NCT00980460 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT00006008 ·Status: COMPLETED ·Phase: PHASE2

Dose-Ranging Safety and Efficacy Study of Topical Creams Containing API 31510 for the Treatment of in Situ Cutaneous Squamous Cell Carcinoma

NCT00605709 ·Status: WITHDRAWN ·Phase: PHASE2

Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors

NCT00058253 ·Status: COMPLETED ·Phase: PHASE1

Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma

NCT05411237 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma

NCT00003718 ·Status: UNKNOWN ·Phase: PHASE2

Study to Determine the Effectiveness of GSK1120212 in BRAF Mutation-positive Melanoma Previously Treated With or Without a BRAF Inhibitor

NCT01037127 ·Status: COMPLETED ·Phase: PHASE2

Antineoplaston Therapy in Treating Patients With Primary Liver Cancer

NCT00003530 ·Status: TERMINATED ·Phase: PHASE2

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Cutaneous Squamous Cell Carcinoma In Situ

NCT00329121 ·Status: COMPLETED ·Phase: PHASE2